Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.
Teprotumumab Improves Thyroid Eye Disease Across Phenotypes
NEW ORLEANS — Comparable improvements were observed with teprotumumab (Tepezza) between patients with age-related phenotypic I or II thyroid eye disease, according to results from